Clinical Trial Update: A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dosing, efficacy, and safety of oral cysteamine in adults experiencing cystic fibrosis exacerbations has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Cysteamine (cysteamine)

Snippet

Sponsor: NovaBiotics Ltd. | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2021-04-14